دورية أكاديمية

Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3

التفاصيل البيبلوغرافية
العنوان: Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3
المؤلفون: Chengliang Zhu, Hengcheng Zhu, Hui Song, Limin Xu, Longxuan Li, Fang Liu, Xinghui Liu
المصدر: Lipids in Health and Disease, Vol 16, Iss 1, Pp 1-7 (2017)
بيانات النشر: BMC, 2017.
سنة النشر: 2017
المجموعة: LCC:Nutritional diseases. Deficiency diseases
مصطلحات موضوعية: Hepatitis B virus, Apolipoprotein C3, Triglyceride, Very-low-density lipoprotein, Nutritional diseases. Deficiency diseases, RC620-627
الوصف: Abstract Background Hepatitis B virus (HBV) infection in the body can damage liver cells and cause disorders in blood lipid metabolism. Apolipoprotein C3 (ApoC3) plays an important role in the regulation of lipid metabolism, but no study on the HBV regulation of ApoC3 has been reported. This purpose of this study was to investigate the effect of HBV on ApoC3 expression and its regulatory mechanism. Methods The expression levels of ApoC3 mRNA and protein in the human hepatoma cell lines HepG2 and HepG2.2.15 were determined using real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) and Western blot. The HepG2 cells were co-transfected with the ApoC3 gene promoter and either HBV-infected clone pHBV1.3 or its individual genes. The changes in luciferase activity were assayed. The expression levels of ApoC3 mRNA and protein were determined using RT-qPCR and Western blot. The content of ApoC3 in the supernatant of the cultured cells was determined using an enzyme-linked immunosorbent assay (ELISA). The sera were collected from 149 patients with HBV infection and 102 healthy subjects at physical examination as the normal controls. The serological levels of ApoC3 in the HBV group and the normal control group were determined using ELISA. The contents of serum triglyceride (TG) and very-low-density lipoprotein (VLDL) in the HBV patients and the normal control were determined using an automatic biochemical analyser. Results The expression levels of ApoC3 mRNA and protein were lower in the HepG2.2.15 cells than in the HepG2 cells. pHBV1.3 and its X gene could inhibit the activity of the ApoC3 promoter and its mRNA and protein expression. The serum levels of ApoC3, VLDL and TG were 65.39 ± 7.48 μg/ml, 1.24 ± 0.49 mmol/L, and 0.46 ± 0.10 mmol/L in the HBV patients and 41.02 ± 6.88 μg/ml, 0.76 ± 0.21 mmol/L, 0.29 ± 0.05 mmol/L in the normal controls, respectively, statistical analysis revealed significantly lower serum levels of ApoC3, VLDL and TG in HBV patients than in the normal controls (P
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1476-511X
العلاقة: http://link.springer.com/article/10.1186/s12944-017-0607-2Test; https://doaj.org/toc/1476-511XTest
DOI: 10.1186/s12944-017-0607-2
الوصول الحر: https://doaj.org/article/6f09923ca0cc4aaca05780c3634fb4c0Test
رقم الانضمام: edsdoj.6f09923ca0cc4aaca05780c3634fb4c0
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:1476511X
DOI:10.1186/s12944-017-0607-2